Publicacións nas que colabora con Domingo Andres Pascual Figal (11)

2023

  1. Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 704-720

2021

  1. The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status (Scientific Reports, (2020), 10, 1, (13553), 10.1038/s41598-020-70454-8)

    Scientific Reports

  2. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction

    Journal of Molecular and Cellular Cardiology, Vol. 130, pp. 216-233

2018

  1. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction

    Translational Research, Vol. 199, pp. 4-23

2017

  1. Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 10, Núm. 5-6, pp. 460-469

2016

  1. Factor de transcripción TBX1 en el remodelado cardiaco asociado al infarto de miocardio

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1042-1050

2015

  1. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction

    JACC: Heart Failure, Vol. 3, Núm. 1, pp. 50-58

2014

  1. Galectin-3 expression in cardiac remodeling after myocardial infarction

    International Journal of Cardiology, Vol. 172, Núm. 1

  2. Modulation of IL-33/ST2 system in postinfarction heart failure: Correlation with cardiac remodelling markers

    European Journal of Clinical Investigation, Vol. 44, Núm. 7, pp. 643-651